Imke Grimmelmann

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

Jürgen C. Becker, Selma Ugurel, Ulrike Leiter et al. · The Lancet · 2023 · 70 citations

Medicine, Immunology, Oncology +16

Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy – A multicentre study of 90 patients from the German Dermatooncology Group

Imke Grimmelmann, M Momma, Lisa Zimmer et al. · European Journal of Cancer · 2021 · 26 citations · Full text

Life Sciences, Dermatology, Immunology +13

Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor‐associated neurotoxicity

Nora Möhn, Susann Mahjoub, Laura Duzzi et al. · Cancer Medicine · 2023 · 24 citations · Full text

Life Sciences, Immunology, Oncology +17

Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG

Cindy Franklin, Peter J. Mohr, Leonie Bluhm et al. · Journal for ImmunoTherapy of Cancer · 2022 · 19 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

Cindy Franklin, Peter Mohr, Leonie Bluhm et al. · Journal for ImmunoTherapy of Cancer · 2023 · 13 citations · Full text

Medicine, Clinical Sciences, Oncology +17